Added to YB: 2019-02-26
Pitch date: 2019-02-26
CLSD:US [bullish]
Clearside Biomedical, Inc.
-96.23%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space.
Market Cap
$18.9M
Pitch Price
$22.80
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.11
P/E
-0.66
EV/Sales
15.78
Sector
Pharmaceuticals
Category
N/A
Show full summary:
CLEARSIDE BIOMEDICAL INC COM CLSD:US
A summary for this pitch has not been created yet.
Read full article (0 min)